Zicam Maker Hit With Patent Suit Over Nasal Spray Formula

Law360 (September 6, 2019, 4:15 PM EDT) -- The maker of Zicam cold products has been hit with a patent infringement and trade secrets lawsuit alleging it pulled out of a deal to license a competitor’s static electricity technology, then used the formula in its own products anyway.

In a complaint filed in New Jersey federal court Thursday, Somerville-based Trutek Corp. says it wants Bridgewater-based Matrixx Initiatives Inc. and its executives to turn over all profits it made from using Trutek’s electrostatic technology formulas for nasal allergy and infection relief. Trutek claims it was “irreparably damaged” due to Matrixx’s use of its proprietary information and is entitled to compensation,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS